Abstract

Objectives: To evaluate bone loss around implants placed in patients with a history of treated chronic periodontitis and who did or did not attend supportive periodontal therapy, after one year in function. Furthermore, the influence of periodontal biotype and level of plaque was also evaluated. Material and Methods: Forty-nine patients participated voluntarily in the study. All subjects had a history of chronic periodontitis, which had been previously treated. After the active treatment, 27 patients attended supportive periodontal therapy (SPT) and the rest did not (No SPT). The O’Leary plaque index and periodontal biotype were recorded for each subject and 246 Astra Tech® OsseospeedTM implants were radiographically analysed (123 placed in SPT patients and 123 in No SPT patients) at the time of loading and one year later, measuring marginal bone loss with the program Dental Studio NX 6.0®. The statistical analysis was performed with Windows SPSS, applying Pearson’s correlation index and the Kruskal-Wallis and U-Mann Whitney non-parametric tests. Results: Six patients were found to have periimplantitis and sixteen mucositis. The survival rate was 99.59% (100% SPT and 99.18% No SPT). Mean bone loss was 0.39 mm (range [-0.71 - 8.05]). Among SPT patients, 95% of the implants had losses less than or equal to the mean (mean bone loss of 0.16 mm) compared to 53.7% for the No SPT group (mean bone loss of 0.62 mm). A statistically significant relationship was demonstrated between bone loss around the implant and the patient’s periodontal biotype and plaque index. Conclusions: The marginal bone loss around implants in patients with treated chronic periodontitis is minimal if they are in a controlled SPT programme and there is individual control of plaque index. Moreover, the presence of a thin periodontal biotype represents a risk factor for additional bone loss. Key words:Peri-implantitis, chronic periodontitis, bacterial plaque, periodontal biotype.

Highlights

  • Dental implants have become predictable in the treatment of totally or partially edentulous patients [1,2]

  • Mucositis is defined as an inflammatory lesion of infectious origin residing in the periimplant mucosa; when this involves the loss of supporting bone it would be referred to as periimplantitis

  • One implant was lost during this year (Figs. 2,3), rendering a total survival rate of 99.59% (100% for supportive periodontal therapy (SPT) and 99.18% for No SPT)

Read more

Summary

Introduction

Dental implants have become predictable in the treatment of totally or partially edentulous patients [1,2]. Mucositis is defined as an inflammatory lesion of infectious origin residing in the periimplant mucosa; when this involves the loss of supporting bone it would be referred to as periimplantitis. The presence of reddening, inflammation and bleeding on probing would assist in the diagnosis of the first entity and, if an increase in probing depth and suppuration together with marginal supporting bone loss, confirmed by X-ray, is present, it would indicate periimplantitis [4,5]. The objective of this study was to evaluate bone loss around Astra Tech® implants placed in patients with a history of treated chronic periodontitis who did or did not attend supportive periodontal therapy, after one year in function, and the influence that periodontal biotype and level of plaque may have

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call